Showing 1 - 17 results of 17 for search 'S. F. McDermott', query time: 0.06s
Refine Results
-
1
-
2
-
3
-
4
-
5
Anti-inflammatory effects of elexacaftor/tezacaftor/ivacaftor in adults with cystic fibrosis heterozygous for F508del. by Heledd H Jarosz-Griffiths, Lindsey Gillgrass, Laura R Caley, Giulia Spoletini, Ian J Clifton, Christine Etherington, Sinisa Savic, Michael F McDermott, Daniel Peckham
Published 2024-01-01
Article -
6
Anti-inflammatory effects of elexacaftor/tezacaftor/ivacaftor in adults with cystic fibrosis heterozygous for F508del by Heledd H. Jarosz-Griffiths, Lindsey Gillgrass, Laura R. Caley, Giulia Spoletini, Ian J. Clifton, Christine Etherington, Sinisa Savic, Michael F. McDermott, Daniel Peckham
Published 2024-01-01
Article -
7
-
8
Recovery of Bone Marrow Function in VEXAS Syndrome-potential Role for Romiplostim by Adam Al-Hakim, Alyssa Cull, Joanna Topping, Fatima Nadat, Joanna Milek, Razan Alhefzi, Michael F. McDermott, Roger Owen, Catherine Cargo, James Poulter, David G. Kent, Sinisa Savic, on behalf of the ImmunAID consortium*
Published 2023-08-01
Article -
9
Genomic analysis of azithromycin-resistant Salmonella from food animals at slaughter and processing, and retail meats, 2011–2021, United States by Beilei Ge, Sampa Mukherjee, Cong Li, Lucas B. Harrison, Chih-Hao Hsu, Thu-Thuy Tran, Jean M. Whichard, Uday Dessai, Ruby Singh, Jeffrey M. Gilbert, Errol A. Strain, Patrick F. McDermott, Shaohua Zhao
Published 2024-01-01
Article -
10
Treatment-free survival outcomes from the phase II study of nivolumab and salvage nivolumab/ipilimumab in advanced clear cell renal cell carcinoma (HCRN GU16-260-Cohort A) by Michael Hurwitz, Mark Stein, Jeffrey Sosman, David F McDermott, Michael B Atkins, Naomi B Haas, Elizabeth R Plimack, Hans Hammers, Mehmet A Bilen, Meredith M Regan, Moshe C Ornstein, David Einstein, Opeyemi A Jegede, Robert Alter, David J Peace, Paul J Catalano
Published 2024-04-01
Article -
11
Nemvaleukin alfa, a modified interleukin-2 cytokine, as monotherapy and with pembrolizumab in patients with advanced solid tumors (ARTISTRY-1) by Lucy Gilbert, Jameel Muzaffar, Vamsidhar Velcheti, Anna Spreafico, Emiliano Calvo, David F McDermott, Marc S Ernstoff, Valentina Boni, Karl D Lewis, Ira Winer, Olivier Dumas, Aman Chauhan, Arvind Chaudhry, Christoper J Hoimes, Seth D Rosen, Debora S Bruno, James F Strauss, Rita Dalal, Ulka N Vaishampayan, Quincy S Chu
Published 2024-11-01
Article -
12
Treatment-free survival and partitioned survival analysis of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib: 5-year update of C... by Thomas Powles, Laurence Albiges, David F McDermott, Michael B Atkins, Toni K Choueiri, Bernard Escudier, Elizabeth R Plimack, Brian I Rini, Martin H Voss, Hans J Hammers, Chung-Han Lee, Robert J Motzer, Yoshihiko Tomita, Nizar M Tannir, Meredith M Regan, Charlene M Mantia, Lisa Rosenblatt, Opeyemi A Jegede
Published 2024-07-01
Article -
13
A retrospective analysis of High-Dose Interleukin-2 (HD IL-2) following Ipilimumab in metastatic melanoma by Sandra Aung, Sigrun Hallmeyer, David F. McDermott, Joseph I. Clark, Howard L. Kaufman, Gregory A. Daniels, Sapna P. Patel, John M. Kirkwood, Ryan J. Sullivan, Marc S. Ernstoff, Brendan D. Curti, Elizabeth I. Buchbinder, Rene Gonzalez, John M. Richart, Anasuya Gunturi, Jessica Perritt, Janice Dutcher, Girald P. Miletello, Joe Lutzky, Michael A. Morse
Published 2016-11-01
Article -
14
Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of renal cell carcinoma by Michael B. Atkins, David F. McDermott, David I. Quinn, Thomas Olencki, Thomas Hutson, Brian I. Rini, Laura S. Wood, Martin H. Voss, Hans Hammers, William Bro, Ronald M. Bukowski, Bernard Faba, Jo Faba, Robert A. Figlin, Eric Jonasch, Richard W. Joseph, Bradley C. Leibovich, Allan J. Pantuck, Virginia Seery, Christopher G. Wood
Published 2016-12-01
Article -
15
Prognostic significance and immune correlates of CD73 expression in renal cell carcinoma by Neeraj Agarwal, Sabina Signoretti, David F McDermott, Toni K Choueiri, Wanling Xie, John A Steinharter, Nieves Martinez-Chanza, Bradley A McGregor, Lauren C Harshman, Abhishek Tripathi, Xiao X Wei, Edwin Lin, Abdallah Flaifel, Emily N Stern Gatof, Gabrielle Bouchard, Justin H Fleischer, Connor Gray, Charlene Mantia, Linda Thompson, Marios Giannakis
Published 2020-10-01
Article -
16
A one health approach for monitoring antimicrobial resistance: developing a national freshwater pilot effort by Alison M. Franklin, Daniel L. Weller, Lisa M. Durso, Mark Bagley, Benjamin C. Davis, Jonathan G. Frye, Christopher J. Grim, Abasiofiok M. Ibekwe, Michael A. Jahne, Scott P. Keely, Autumn L. Kraft, Betty R. McConn, Richard M. Mitchell, Andrea R. Ottesen, Manan Sharma, Errol A. Strain, Daniel A. Tadesse, Heather Tate, Jim E. Wells, Clinton F. Williams, Kim L. Cook, Claudine Kabera, Patrick F. McDermott, Jay L. Garland
Published 2024-05-01
Article -
17
Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma: 42-month follow-up of a random... by Howard Gurney, Thomas Powles, Asim Amin, Bohuslav Melichar, Camillo Porta, David F McDermott, Toni K Choueiri, Marc-Oliver Grimm, Bernard Escudier, Elizabeth R Plimack, Brian I Rini, Hans J Hammers, Saby George, Robert J Motzer, Alain Ravaud, Osvaldo Arén Frontera, Frede Donskov, Philippe Barthélémy, Viktor Grünwald, Victoria Neiman, Pamela Salman, Christian K Kollmannsberger, Scott S Tykodi, Raya Leibowitz-Amit, Poul F Geertsen, Yoshihiko Tomita, M Brent McHenry, Shruti Shally Saggi, Nizar M Tannir
Published 2020-10-01
Article